01 1Curia
01 1TRIENTINE HCL USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-21
Pay. Date : 2014-05-07
DMF Number : 12659
Submission : 1997-09-18
Status : Active
Type : II
20
Curia New York Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is TRIENTINE HCL USP, with a corresponding US DMF Number 12659.
Remarkably, this DMF maintains an Active status since its submission on September 18, 1997, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 21, 2015, and payment made on May 07, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
